Is Lamivudine Dolutegravir Tablets (Dolutegravir) a blocking drug?
Lamivudine/Dolutegravir is not a typical HIV blocking drug. It is actually an antiretroviral drug (Antiretroviral Therapy, ART), mainly used to treat human immunodeficiency virus (HIV) infection.
Blocking drugs usually refer to drugs that preventHIV infection, such as prognostic exposure prophylaxis (PEP) and advance exposure prophylaxis (PrEP) drugs. PEP is a strategy of taking medications to prevent infection in the event of possible exposure to HIV. And PrEP refers to the strategy of taking drugs regularly to prevent HIV infection among high-risk groups. These drugs usually contain a combination of anti-HIV drugs, such as cytidine triphosphate (Tenofovir) and veramibine (Emtricitabine), to prevent the spread of HIV.

In contrast, lamivudine dolutegravir is a treatment used to control viral replication in patients who are already infected withHIV. It contains two anti-HIV drugs: lamivudine (Lamivudine) and dolutegravir (Dolutegravir), their role is to inhibit the replication of HIV viruses, slow down the progression of the disease, and improve the function of the patient's immune system, thereby maintaining health and reducing the viral load of HIV in the body.
In short, lamivudine dolutegravir tablets are an antiretroviral drug used to treat patients infected withHIV, not a blocking drug. It is not used for prevention.HIV infection. Preventing HIV infection often requires other types of medications, such as PEP and PrEP. Patients should follow their doctor's advice and use the correct medication that suits their needs.
Lamivudine dolutegravir tablets have been launched in China and have been included in medical insurance. Patients can buy them in domestic hospital pharmacies at a price of about more than 1,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement information. The cheaper ones abroad are mainly Indian generic drugs, which cost more than 200 yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)